Radiosurgery for Patients Recurrent Oligometastatic Disease

NACompletedINTERVENTIONAL
Enrollment

173

Participants

Timeline

Start Date

June 28, 2011

Primary Completion Date

October 13, 2020

Study Completion Date

October 11, 2022

Conditions
Recurrent Oligometastatic Disease
Interventions
RADIATION

Stereotactic Radiosurgery (SRS)

Dose and fractionation will be dependent on the lesion location and lesion size and is up to the exact fractionation and dose is at the discretion of the treating physician. A minimum of 48 hours must be used in between SRS treatments at each site. Note that patients can have SRS everyday or multiple SRS sessions in one day as long as the minimum time for each treatment site is met. For example, if two lung lesions, brain, adrenal, and liver sites were being treated both lung sites could be treated Monday, Wednesday, and Friday and the adrenal, liver and brain lesions treated Tuesday, Thursday

Trial Locations (1)

15232

UPMC Hillman Cancer Center - Radiation Oncology, Pittsburgh

All Listed Sponsors
lead

Steven Burton

OTHER

NCT01345552 - Radiosurgery for Patients Recurrent Oligometastatic Disease | Biotech Hunter | Biotech Hunter